GlobalData on MSN24d
EU set to approve AstraZeneca’s Imfinzi-chemo combo for NSCLCAstraZeneca's Imfinzi (durvalumab) plus chemotherapy combo has received the European Medicines Agency’s (EMA) Committee for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback